Insulet Corp at Raymond James Institutional Investors Conference Transcript
All right. Good afternoon. I think we're going to get started here. Thanks for joining us, and congrats on passing the COVID protocols. My name is Jayson Bedford. I cover medical devices here at Raymond James, and it's really our privilege to have with us the senior management team from Insulet. With us, we have the company's CEO, Shacey Petrovic. We have the company's CFO, Wayde McMillan. And Deb Gordon, VP of Investor Relations, is down in front here.
So with that, I'm going to hand it off to Shacey, and then we'll jump into some more interactive Q&A.
Great. Thanks, Jayson. And we appreciate being here, you hosting us and for the opportunity to share some opening remarks. What I thought I would just share is, it is an incredibly exciting time today at Insulet. And for our company and for our customers, which you'll see on the screen behind me, these are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
